A comparison of the efficacy and tolerability of treating primary nocturnal enuresis with Solifenacin Plus Desmopressin, Tolterodine Plus Desmopressin, and Desmopressin alone: a randomized controlled clinical trial [PDF]
International Brazilian Journal of Urology, 2020 Introduction: Nocturnal enuresis (enuresis) is one of the most common developmental problems of childhood, which has often a familial basis, causes mental and psychological damage to the child and disrupts family solace.
Parvin Mousavi Ghanavati +2 more
doaj +2 more sources
Desmopressin in nocturnal enuresis. [PDF]
Archives of Disease in Childhood, 1982 The response of desamino-D-arginine vasopressin (DDAVP) was investigated in 32 enuretic children in a double-blind clinical study. The 15 children treated with DDAVP showed a significant reduction in the incidence of bed wetting--from 18.7 +/- 6.5 to 6.5 +/- 9.2 wet nights per 30 days.
H. Boichis +5 more
openaire +5 more sources
Drugs, 2005 Desmopressin, a synthetic antidiuretic hormone analogue, is the only drug currently approved for the treatment of nocturia associated with nocturnal polyuria or multiple sclerosis (MS). Compared with vasopressin, desmopressin has a longer lasting and more potent antidiuretic effect and is devoid of vasopressor and uterotonic effects.
Greg L. Plosker, Risto S Cvetković
openaire +4 more sources
Relationship between use of desmopressin in male patients with lower urinary tract symptoms and occurrence of hyponatremia: A nationwide population-based study using the National Health Insurance Service database [PDF]
Investigative and Clinical UrologyPurpose: Desmopressin, frequently prescribed for nocturia, is associated with an elevated risk of hyponatremia. This study examined the incidence and risk factors of hyponatremia in male patients with benign prostatic hyperplasia using nationwide Korean ...
Byeong Jo Jeon +3 more
doaj +2 more sources
Global estimation of the bleeding episodes treatable with desmopressin in von Willebrand disease and hemophilia A [PDF]
HaematologicaDesmopressin increases plasma factor VIII and von Willebrand factor in non-severe hemophilia A (Hem A) and type 1 von Willebrand disease (VWD), following intravenous infusions, subcutaneous injections or nasal spray.
Alessandro Gringeri +4 more
doaj +2 more sources
Desmopressin for bedwetting. [PDF]
Archives of Disease in Childhood, 1992 R E Morton, M Daniels
+7 more sources
Desmopressin prescription safety in adult inpatients: a real-world tertiary centre experience [PDF]
Endocrine ConnectionsOmissions or delays in desmopressin can result in serious patient harm in patients with arginine vasopressin deficiency (AVP-D), formally known as cranial diabetes insipidus.
Muhammad Fahad Arshad +7 more
doaj +2 more sources
Randomized Double-Blind Placebo-Controlled Trial of Desmopressin for Post–Kidney Biopsy Bleeding [PDF]
Kidney International ReportsIntroduction: This study evaluated the efficacy and safety of desmopressin in reducing postbiopsy bleeding in patients undergoing kidney biopsy, a common complication requiring effective prevention strategies.
Narayan Prasad +14 more
doaj +2 more sources
Response to desmopressin is influenced by the genotype and phenotype in type 1 von Willebrand disease (VWD): results from the European Study MCMDM-1VWD [PDF]
Blood, 2008 Giancarlo Castaman +2 more
exaly +2 more sources
Asian Journal of Urology, 2022 Objective: To evaluate the efficacy and safety of desmopressin on frequency and urgency in female patients with overactive bladder (OAB) and nocturia.
Bara Barakat +4 more
doaj +1 more source